Literature DB >> 22411338

Treatment of talocalcaneal coalitions.

George D Gantsoudes1, Joanna H Roocroft, Scott J Mubarak.   

Abstract

BACKGROUND: The purpose of this study was to review outcomes of patients treated for symptomatic talocalcaneal coalition with resection and interposition of fat graft.
METHODS: A retrospective review was performed on all patients who underwent surgical treatment for symptomatic talocalcaneal coalition over a 13-year period. Ninety-three feet were treated with excision and fat graft interposition by 6 surgeons. All patients underwent a chart review. Patient's outcome was assessed at the last follow-up using the American Orthopaedic Foot and Ankle Society Hindfoot scale. Postoperative computed tomography scans were available for 20 feet.
RESULTS: Forty-nine feet had follow-up of at least 12 months and had a score obtained through the American Orthopaedic Foot and Ankle Society Hindfoot scale. At an average of 42.6 months of follow-up, the average score obtained was 90/100 (excellent). The postoperative computed tomography scans demonstrated 1 recurrence (3%), which was treated with repeat excision. An additional patient was reoperated for failure to excise the coalition completely. Eleven patients (34%) underwent a subsequent surgery to correct the alignment of the foot. To the best of our knowledge, none of the patients excluded because of short follow-up had repeat surgery or recurrence.
CONCLUSIONS: A symptomatic talocalcaneal coalition can be treated with excision and fat graft interposition, and achieve good to excellent results in 85% of patients. Patients should be counseled that a subset may require further surgery to correct malalignment. LEVEL OF EVIDENCE: Level IV-case series.

Entities:  

Mesh:

Year:  2012        PMID: 22411338     DOI: 10.1097/BPO.0b013e318247c76e

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  9 in total

1.  [Surgical treatment of talocalcaneal coalition : Experience with 80 cases of pediatric or adolescent patients].

Authors:  J Hamel; M Nell; C Rist
Journal:  Orthopade       Date:  2016-12       Impact factor: 1.087

2.  Resection of Tarsal Coalition in 27 Children with 2 Years Follow-Up - Patient-Reported Outcomes Using the Validated Oxford Ankle Foot Questionnaire.

Authors:  Ahmed Abdul-Hussein Abood; Bjarne Møller-Madsen; Jan Duedal Rölfing; Alexios Iliadis; Manoj Ramachandran; Ole Rahbek
Journal:  Iowa Orthop J       Date:  2021-12

Review 3.  [Diagnosis and treatment of tarsal coalitions and synostoses in children and adolescents].

Authors:  J Hamel
Journal:  Orthopade       Date:  2013-06       Impact factor: 1.087

4.  Sacroiliac Coalition: First Description and Report of a Successful Resection.

Authors:  Axel Greiner; Andrea Baur-Melnyk; Sabina Berezowska; Melvin D'Anastasi; Christof Birkenmaier
Journal:  Global Spine J       Date:  2015-01-30

5.  Treatment of hindfoot and ankle pathologies with posterior arthroscopic techniques.

Authors:  Tahir Ögüt; N Selcuk Yontar
Journal:  EFORT Open Rev       Date:  2017-05-11

6.  Characteristics and reoperation rates of paediatric tarsal coalitions: a population-based study.

Authors:  Taylor J Jackson; Smitha E Mathew; A Noelle Larson; Anthony A Stans; Todd A Milbrandt
Journal:  J Child Orthop       Date:  2020-12-01       Impact factor: 1.548

7.  Tarsal coalition resections: a long-term retrospective analysis of 97 resections in 78 patients.

Authors:  Amol Saxena; Ryan Allen; Anthony Wright; Filippo Migliorini; Nicola Maffulli
Journal:  J Orthop Surg Res       Date:  2022-10-17       Impact factor: 2.677

8.  Results of Nonoperative Treatment for Symptomatic Tarsal Coalitions.

Authors:  Eric Shirley; Radu Gheorghe; Kevin M Neal
Journal:  Cureus       Date:  2018-07-08

9.  Operative versus nonoperative treatment in children with painful rigid flatfoot and talocalcaneal coalition.

Authors:  Giovanni Luigi Di Gennaro; Stefano Stallone; Eleonora Olivotto; Paola Zarantonello; Marina Magnani; Tullia Tavernini; Stefano Stilli; Giovanni Trisolino
Journal:  BMC Musculoskelet Disord       Date:  2020-03-24       Impact factor: 2.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.